Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
acute migrane
bain capital
bausch health
biology
breast cancer
clinical trials
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
endeavor
fundings & exits
generic drug
glaxosmithkline
health
impel neuropharma
life sciences
medical device
migraine
multiple myeloma
national blog main
national organization for rare disorders
new york
new york blog main
new york top stories
nirogacestat
orbimed
peter diamandis
ra capital
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
san francisco blog main
san francisco top stories
satsuma pharmaceuticals
shin nippon biomedical laboratories
singularity
singularity university
springworks therapeutics
startups
What
spinout
2
×
activity
biopharmaceutical
biotech
called
celgene
cells
celularity
companies
company
creating
days
derived
diamandis
dog
drug
endeavor
firm
focus
founder
gene
global
hasn’t
hold
human
ipo
ipos
key
leading
line
medicine
migraine
million
myriad
new
peter
pfizer
place
placenta
placentas
Language
unset
Current search:
spinout
×
biotech
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas
